Regeneron Seeks FDA Emergency Clearance for Covid-19 Therapy

Antibody cocktail showed promise in early-stage clinical trial
Trump was given Regeneron therapy for coronavirus last week

Regeneron Pharmaceuticals Inc headquarters in Tarrytown, N.Y., U.S., on June 12.
Photographer: Michael Nagle/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Robert Langreth

October 7, 2020 at 9:45 PM EDT

Updated on

October 7, 2020 at 9:52 PM EDT

This article is for subscribers only.

Regeneron Pharmaceuticals Inc. said it has asked federal regulators to authorize its antibody treatment for Covid-19 for emergency use.

President Donald Trump received the antibody cocktail last Friday under a compassionate use program after becoming sick with the coronavirus. Trump hailed Regeneron’s treatment in a video posted on Twitter Wednesday, saying he would authorize its emergency use and make it available to Americans for free.